Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Thought Leadership
Latest Report
EvaluatePharma World Preview 2019, Outlook to 2024
Worldwide prescription drugs sales predicted to reach $1.18trn in 2024, with a compound annual growth of 6.9%, significantly higher than the 1.7% CAGR between 2011-2018. The latest annual World Preview 2019, Outlook to 2024 comes at one of the most exciting points in the industry’s development. There is significant optimism around the launch of…
Report library
EP Vantage Pharma, Biotech and Medtech 2017 In Review
Report Highlights All major healthcare indices climbed in 2017, echoing wider stock market strength The $80bn spent on pharma & biotech acquisitions in 2017 makes…
EP Vantage 2018 Preview
Report Highlights M&A activity expected to climb after slow 2017 – US tax reform a deciding factor for big deals Another big year predicted for venture financing…
Evaluate Forecasting Excellence: The Value of Outliers in Consensus Forecasting
Key Report Themes Upside/downside radio metrics that identify companies that could either outperform in the coming years or are at risk Companies that could follow a…
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.